trilostane has been researched along with Adenoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A | 1 |
| Kimura, M; Nakada, T | 1 |
| Füessl, HS | 1 |
| Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M | 1 |
| Greminger, P; Groth, H; Vetter, H; Vetter, W; Winterberg, B | 1 |
5 other study(ies) available for trilostane and Adenoma
| Article | Year |
|---|---|
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; COVID-19; Dihydrotestosterone; Disease Progression; Female; Guanidines; Health Personnel; Heparin; Humans; Japan; Metyrapone; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pregnenediones; Pyrazines; SARS-CoV-2; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Primary aldosteronism associated with chronic renal failure. Report of a case.
Topics: Adenoma; Adrenal Gland Neoplasms; Combined Modality Therapy; Dihydrotestosterone; Furosemide; Humans; Hyperaldosteronism; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1984 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Syndrome; Diagnosis, Differential; Dihydrotestosterone; Diuretics; Enzyme Inhibitors; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Angiography; Mineralocorticoid Receptor Antagonists; Pituitary Neoplasms; Spironolactone; Tomography, X-Ray Computed | 2002 |
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Female; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors; Progesterone; Radioimmunoassay; Renin-Angiotensin System; Testosterone | 1985 |
Primary aldosteronism: treatment with trilostane.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Blood Pressure; Dihydrotestosterone; Electrolytes; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; Male; Middle Aged; Renin-Angiotensin System | 1985 |